Skip to main content
Log in

Limbal conjunctival versus amniotic membrane in the intraoperative application of mitomycin C for recurrent pterygium: a randomized controlled trial

  • Cornea
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

This study compared the outcomes of a limbal conjunctival autograft (LCAG) with those of an amniotic membrane graft (AMG) followed by intraoperative 0.02 % mitomycin C (MMC) to treat recurrent pterygium.

Methods

In this randomized controlled trial, ninety-six eyes with recurrent pterygium were enrolled and randomly allocated into two groups using a computer-generated random number table. Pterygium removal was followed by intraoperative 0.02 % MMC for 3 min and then either LCAG or AMG transplantation. The major outcomes were recurrence rate, conjunctival inflammation grade, healing time of the corneal epithelial defect, eye-movement amplitude (EMA), uncorrected distance visual acuity (UDVA), and complications.

Results

A follow-up of 12 months was conducted for 93 eyes of 82 patients. Grade D (recurrence) presented in one eye of the LCAG group and five eyes of the AMG group, with no between-group difference (p = 0.196). However, Grades A, B, and C presented in 46, zero and zero eyes of the LCAG group respectively, and in 37, two and two eyes of the AMG group respectively, with the surgical bed generally showing a better appearance in the LCAG group than in the AMG group (p = 0.008). Compared with baseline values, the postoperative EMA improved significantly in both groups (p < 0.001 for the LCAG group; p = 0.001 for the AMG group), as did UDVA (p = 0.005 for the LCAG group; p = 0.012 for the AMG group). No between-group differences were found in terms of the healing time for epithelial defect, conjunctival inflammation grade, or the frequency of complications such as punctate epithelial keratitis, episcleral melting, corneal pannus, and delayed corneal epithelium healing.

Conclusions

LCAG transplantation with intraoperative 0.02 % MMC is as efficacious in treating recurrent pterygium as AMG transplantation with MMC. The former procedure results in an attractive cosmetic appearance but might result in limbal damage in some eyes. The surgeon’s familiarity with these procedures should determine the method of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Hirst LW (2003) The treatment of pterygium. Surv Ophthalmol 48:145–180. doi:10.1016/S0039-6257(02)00463-0

    Article  PubMed  Google Scholar 

  2. Shimazaki J, Shinozaki N, Tsubota K (1998) Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol 82:235–240. doi:10.1136/bjo.82.3.235

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Shimazaki J, Kosaka K, Shimmura S, Tsubota K (2003) Amniotic membrane transplantation with conjunctival autograft for recurrent pterygium. Ophthalmology 110:119–124. doi:10.1016/S0161-6420(02)01453-7

    Article  PubMed  Google Scholar 

  4. Dekaris I, Gabrić N, Karaman Z, Mravicić I, Kastelan S (2002) Limbal-conjunctival autograft transplantation for recurrent pterygium. Eur J Ophthalmol 12:177–182

    CAS  PubMed  Google Scholar 

  5. Tan DT, Chee SP, Dear KB, Lim AS (1997) Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol 115:1235–1240. doi:10.1001/archopht.1997.01100160405001

    Article  CAS  PubMed  Google Scholar 

  6. Verma N, Garap JA, Maris R, Kerek A (1998) Intraoperative use of mitomycin C in the treatment of recurrent pterygium. P N G Med J 41:37–42

    CAS  PubMed  Google Scholar 

  7. Mastropasqua L, Carpineto P, Ciancaglini M, Enrico Gallenga P (1996) Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium. Br J Ophthalmol 80:288–291. doi:10.1136/bjo.80.4.288

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Lam DS, Wong AK, Fan DS, Chew S, Kwok PS, Tso MO (1998) Intraoperative mitomycin C to prevent recurrence of pterygium after excision: a 30-month follow-up study. Ophthalmology 105:901–904. doi:10.1016/S0161-6420(98)95034-5 [Discussion:904–905]

    Article  CAS  PubMed  Google Scholar 

  9. Kaufman SC, Jacobs DS, Lee WB, Deng SX, Rosenblatt MI, Shtein RM (2013) Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology. Ophthalmology 120:201–208. doi:10.1016/j.ophtha.2012.06.066

    Article  PubMed  Google Scholar 

  10. Al Fayez MF (2002) Limbal versus conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 109:1752–1755. doi:10.1016/S0161-6420(02)01160-0

    Article  PubMed  Google Scholar 

  11. Dekaris I, Gabrić N, Karaman Z, Mravicić I, Kastelan S, Spoljarić N (2001) Pterygium treatment with limbal-conjunctival autograft transplantation. Coll Anthropol 25(Suppl):7–12

    Google Scholar 

  12. Gris O, Güell JL, del Campo Z (2000) Limbal–conjunctival autograft transplantation for the treatment of recurrent pterygium. Ophthalmology 107:270–273. doi:10.1016/S0161-6420(99)00041-X

    Article  CAS  PubMed  Google Scholar 

  13. Rao SK, Lekha T, Mukesh BN, Sitalakshmi G, Padmanabhan P (1998) Conjunctival–limbal autografts for primary and recurrent pterygia: technique and results. Indian J Ophthalmol 46:203–209

    CAS  PubMed  Google Scholar 

  14. Mutlu FM, Sobaci G, Tatar T, Yildirim E (1999) A comparative study of recurrent pterygium surgery: limbal conjunctival autograft transplantation versus mitomycin C with conjunctival flap. Ophthalmology 106:817–821. doi:10.1016/S0161-6420(99)90172-0

    Article  CAS  PubMed  Google Scholar 

  15. Salman AG, Mansour DE (2011) The recurrence of pterygium after different modalities of surgical treatment. Saudi J Ophthalmol 25:411–415. doi:10.1016/j.sjopt.2010.10.013

    Article  PubMed  Google Scholar 

  16. Prabhasawat P, Barton K, Burkett G, Tseng SC (1997) Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology 104:974–985. doi:10.1016/S0161-6420(97)30197-3

    Article  CAS  PubMed  Google Scholar 

  17. Solomon A, Pires RT, Tseng SC (2001) Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology 108:449–460. doi:10.1016/S0161-6420(00)00567-4

    Article  CAS  PubMed  Google Scholar 

  18. Ma DH, See LC, Hwang YS, Wang SF (2005) Comparison of amniotic membrane graft alone or combined with intraoperative mitomycin C to prevent recurrence after excision of recurrent pterygia. Cornea 24:141–150. doi:10.1097/01.ico.0000141237.71837.d8

    Article  PubMed  Google Scholar 

  19. Fakhry MA (2011) The use of mitomycin C with autologous limbal-conjunctival autograft transplantation for management of recurrent pterygium. Clin Ophthalmol 5:123–127. doi:10.2147/OPTH.S16474

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Yao Y-F, Qiu W-Y, Zhang Y-M, Tseng SC (2006) Mitomycin C, amniotic membrane transplantation and limbal conjunctival autograft for treating multirecurrent pterygia with symblepharon and motility restriction. Graefes Arch Clin Exp Ophthalmol 244:232–236. doi:10.1007/s00417-005-0010-y

    Article  PubMed  Google Scholar 

  21. Nabawi KS, Ghonim MA, Ali MH (2003) Evaluation of limbal conjunctival autograft and low-dose mitomycin C in the treatment of recurrent pterygium. Ophthalmic Surg Lasers Imaging 34:193–196

    PubMed  Google Scholar 

  22. Katircioğlu YA, Altiparmak UE, Duman S (2007) Comparison of three methods for the treatment of pterygium: amniotic membrane graft, conjunctival autograft and conjunctival autograft plus mitomycin C. Orbit 26:5–13. doi:10.1080/01676830600972724

    Article  PubMed  Google Scholar 

  23. Zheng K, Cai J, Jhanji V, Chen H (2012) Comparison of pterygium recurrence rates after limbal conjunctival autograft transplantation and other techniques: meta-analysis. Cornea 31:1422–1427. doi:10.1097/ICO.0b013e31823cbecb

    Article  PubMed  Google Scholar 

  24. Kheirkhah A, Hashemi H, Adelpour M, Nikdel M, Rajabi MB, Behrouz MJ (2012) Randomized trial of pterygium surgery with mitomycin C application using conjunctival autograft versus conjunctival-limbal autograft. Ophthalmology 119:227–232. doi:10.1016/j.ophtha.2011.08.002

    Article  PubMed  Google Scholar 

  25. Young AL, Ho M, Jhanji V, Cheng LL (2013) Ten-year results of a randomized controlled trial comparing 0.02% mitomycin C and limbal conjunctival autograft in pterygium surgery. Ophthalmology 120:2390–2395. doi:10.1016/j.ophtha.2013.05.033

    Article  PubMed  Google Scholar 

  26. Hirst LW (2009) Recurrent pterygium surgery using pterygium extended removal followed by extended conjunctival transplant: recurrence rate and cosmesis. Ophthalmology 116:1278–1286. doi:10.1016/j.ophtha.2009.01.044

    Article  PubMed  Google Scholar 

  27. Zhou S, Chen J, Feng J (2003) The effects of amniotic membrane on polymorphonuclear cells. Chin Med J (Engl) 116:788–790

    Google Scholar 

  28. Kheirkhah A, Casas V, Sheha H, Raju VK, Tseng SC (2008) Role of conjunctival inflammation in surgical outcome after amniotic membrane transplantation with or without fibrin glue for pterygium. Cornea 27:56–63. doi:10.1097/ICO.0b013e31815873da

    Article  PubMed  Google Scholar 

  29. Wei S, Chan L, Cui Y (2005) Limbal epithelial autograft and amniotic membrane transplantation for pterygium in 107 cases. Int J Ophthalmol 5:583–585

    Google Scholar 

  30. Sippel KC, Ma JJ, Foster CS (2001) Amniotic membrane surgery. Curr Opin Ophthalmol 12:269–281. doi:10.1097/00055735-200108000-00006

    Article  CAS  PubMed  Google Scholar 

  31. Katırcıoglu YA, Altiparmak U, Engur Goktas S, Cakir B, Singar E, Ornek F (2015) Comparison of two techniques for the treatment of recurrent pterygium: amniotic membrane vs conjunctival autograft combined with mitomycin C. Semin Ophthalmol 30:321–327. doi:10.3109/08820538.2013.874468

    Article  PubMed  Google Scholar 

  32. Ratnalingam V, Eu AL, Ng GL, Taharin R, John E (2010) Fibrin adhesive is better than sutures in pterygium surgery. Cornea 29:485–489. doi:10.1097/ICO.0b013e3181c29696

    Article  PubMed  Google Scholar 

  33. Sridhar MS, Vemuganti GK, Bansal AK, Rao GN (2001) Impression cytology-proven corneal stem cell deficiency in patients after surgeries involving the limbus. Cornea 20:145–148. doi:10.1097/00003226-200103000-00005

    Article  CAS  PubMed  Google Scholar 

  34. Kheirkhah A, Nazari R, Nikdel M, Ghassemi H, Hashemi H, Behrouz MJ (2011) Postoperative conjunctival inflammation after pterygium surgery with amniotic membrane transplantation versus conjunctival autograft. Am J Ophthalmol 152:733–738. doi:10.1016/j.ajo.2011.04.013

    Article  PubMed  Google Scholar 

  35. Dua HS (1998) The conjunctiva in corneal epithelial wound healing. Br J Ophthalmol 82:1407–1411. doi:10.1136/bjo.82.12.1407

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Dua HS, Azuara-Blanco A (2000) Autologous limbal transplantation in patients with unilateral corneal stem cell deficiency. Br J Ophthalmol 84:273–278. doi:10.1136/bjo.84.3.273

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. McCluskey P, Powell RJ (2004) The eye in systemic inflammatory diseases. Lancet 364(9451):2125–2133. doi:10.1016/S0140-6736(04)17554-5

    Article  PubMed  Google Scholar 

  38. Tsai YY, Lin JM, Shy JD (2002) Acute scleral thinning after pterygium excision with intraoperative mitomycin C: a case report of scleral dellen after bare sclera technique and review of the literature. Cornea 21:227–229. doi:10.1097/00003226-200203000-00022

    Article  PubMed  Google Scholar 

  39. Karalezli A, Kucukerdonmez C, Borazan M, Akova YA (2010) Successful treatment of necrotizing scleritis after conjunctival autografting for pterygium with amniotic membrane transplantation. Orbit 29:88–90. doi:10.3109/01676830903297563

    Article  PubMed  Google Scholar 

  40. Hirst LW, Sebban A, Chant D (1994) Pterygium recurrence time. Ophthalmology 101:755–758. doi:10.1016/S0161-6420(94)31270-X

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The study was supported in part by “Sun Yat-Sen University Clinical Research 5010 Program” in China (grant number: 2014015). This funding organization played no role in the design or performance of this research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shiyou Zhou.

Ethics declarations

Funding

The “Sun Yat-Sen University Clinical Research 5010 Program” in China (grant number: 2014015) funded this study.

Conflict of interest

The authors declare no financial or non-financial conflicts of interest. The authors had full control over the primary data, and they agree to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review their data upon request.

Ethical approval

All of the procedures performed in studies involving human participants were conducted in accordance with the ethical standards of the institutional and/or national research committees and in light of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all participants included in this study.

Additional information

This study was registered at http://www.clinicaltrials.gov (ClinicalTrials.gov identifier: NCT01319721).

Rongxin Chen, Guofu Huang, and Shu Liu contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, R., Huang, G., Liu, S. et al. Limbal conjunctival versus amniotic membrane in the intraoperative application of mitomycin C for recurrent pterygium: a randomized controlled trial. Graefes Arch Clin Exp Ophthalmol 255, 375–385 (2017). https://doi.org/10.1007/s00417-016-3509-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-016-3509-5

Keywords

Navigation